Brain cells that reduce effect of cocaine identified

Image
IANS Toronto
Last Updated : May 20 2016 | 2:48 PM IST

Researchers have discovered a type of brain cells that play a key role in reducing the effects of cocaine on the brain.

The discovery establishes that microglia cells can diminish the adverse changes to neural circuitry brought on by the chronic use of cocaine and has significant implications for developing an effective treatment for addiction.

Microglia may not be as well known as neurons, the brain cells that relay messages, but they have many important functions.

They constantly monitor their environment, and can act to maintain normal brain functioning.

When they find something amiss, they can produce molecules that instruct neurons to make adaptive changes to their connections. One such example is the inflammatory molecule known as tumor necrosis factor (TNF).

"What we discovered is that cocaine activates these microglia, which causes the release of an inflammatory signal which then tries to reverse the changes that cocaine is inducing in the neurons," said the study's senior author David Stellwagen, associate professor at McGill University in Montreal, Canada.

The study was published in the journal Neuron.

Using a mouse model, the researchers detected this microglia-mediated reversal.

In further experiments the team used a pharmaceutical agent that stimulates microglial production of the inflammatory molecule known as tumour necrosis factor.

The researchers observed that a cocaine-induced behavioural change in mice, the progressive increase in movement induced by cocaine, was reduced in the animals who received this agent.

This exciting result holds promise for one day developing treatments that could cut down on drug relapse rates, which can run as high as 80 percent.

"If we could develop a treatment that would suppress the craving that addicts have in stressful situations, or when they are re-exposed to situations in which they'd normally be taking the drug, that may allow them to avoid relapse," Stellwagen said.

"And that's really the therapeutic goal of the work we have been doing," Stellwagen noted.

--IANS

gb/bg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 20 2016 | 2:38 PM IST

Next Story